These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2423889)

  • 1. [HLA system and relationship between microorganisms and host; an important factor in vaccination?].
    van Eden W
    Ned Tijdschr Geneeskd; 1986 Apr; 130(17):772-5. PubMed ID: 2423889
    [No Abstract]   [Full Text] [Related]  

  • 2. Low T lymphocyte responsiveness to Mycobacterium leprae antigens in association with HLA-DR3.
    van Eden W; Elferink BG; de Vries RR; Leiker DL; van Rood JJ
    Clin Exp Immunol; 1984 Jan; 55(1):140-8. PubMed ID: 6362932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
    Svensson M; Pfeifer J; Stockinger B; Wick MJ
    Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Presentation of antigen and MHC-restricted unresponsiveness.
    Ríhová B
    Folia Biol (Praha); 1995; 41(3-4):140-62. PubMed ID: 7589711
    [No Abstract]   [Full Text] [Related]  

  • 5. HLA-DR3 associated genetic control of response to multiple skin tests with new tuberculins.
    van Eden W; de Vries RR; Stanford JL; Rook GA
    Clin Exp Immunol; 1983 May; 52(2):287-92. PubMed ID: 6407794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of mycobacterial peptide epitopes recognized by CD4+ T cells in association with multiple major histocompatibility complex class II molecules.
    Mustafa AS
    Nutrition; 1995; 11(5 Suppl):657-60. PubMed ID: 8748245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular aspects of the role of class II MHC molecules in antigen presentation to T cells.
    Freed JH; Rosloniec EF
    Year Immunol; 1988; 3():161-78. PubMed ID: 2450430
    [No Abstract]   [Full Text] [Related]  

  • 8. Antigen presentation by interferon-gamma-treated endothelial cells and fibroblasts: differential ability to function as antigen-presenting cells despite comparable Ia expression.
    Geppert TD; Lipsky PE
    J Immunol; 1985 Dec; 135(6):3750-62. PubMed ID: 3934267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Migration inhibition factor secreting human T-cell lines reactive to PPD: a study of their antigen specificity, MHC restriction and the use of Epstein-Barr virus-transformed B-cell lines as requirement for antigen-presenting cells.
    Vyakarnam A; Lachmann PJ
    Immunology; 1984 Dec; 53(4):601-10. PubMed ID: 6209204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major histocompatibility complex in man.
    Buc M
    Folia Biol (Praha); 1993; 39(5):223-42. PubMed ID: 8206168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA-peptide complex and immunity-related diseases].
    Matsushita S
    Rinsho Byori; 1999 Jun; 47(6):511-8. PubMed ID: 10434567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tolerance, and Mhc-controlled nonresponsiveness: are they related to each other?
    Klein J
    Prog Clin Biol Res; 1989; 288():119-25. PubMed ID: 2497471
    [No Abstract]   [Full Text] [Related]  

  • 14. Antigen processing and presentation. The biologic role of MHC molecules in determinant selection.
    Benacerraf B
    J Immunol; 1988 Oct; 141(7 Suppl):S17-20. PubMed ID: 2459216
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigen presentation and recognition in bacterial infections.
    Kaufmann SH; Schaible UE
    Curr Opin Immunol; 2005 Feb; 17(1):79-87. PubMed ID: 15653315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of peptides associated with class II MHC molecules, HLA-DR3: implication for the prediction of peptides useful for vaccines].
    Georges B; Gras-Masse H; Maes P; Capron A; Tartar A; Auriault C
    C R Acad Sci III; 1996 Dec; 319(12):1119-25. PubMed ID: 9091183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Personalized vaccination? II. The role of natural microbiota in a vaccine-induced immunity.
    Długońska H; Grzybowski M
    Wiad Parazytol; 2011; 57(2):71-6. PubMed ID: 21682089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-class II-associated control of antigen recognition by T cells in leprosy: a prominent role for the 30/31-kDa antigens.
    Thole JE; Janson AA; Cornelisse Y; Schreuder GM; Wieles B; Naafs B; de Vries RR; Ottenhoff TH
    J Immunol; 1999 Jun; 162(11):6912-8. PubMed ID: 10352313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural requirements for class II molecule recognition by antibodies and T cell antigen receptors.
    McKean DJ
    Chem Immunol; 1989; 46():49-84. PubMed ID: 2482039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.